gdc
ImmunotherapyLung Cancer

Immune Checkpoint Inhibitors Offer New Hope for Patients with Lung Cancer

Several immune checkpoint inhibitors are now approved for patients with non–small-cell lung cancer, giving hope to patients living with this disease.
November 2018 Volume 4 – Lung Cancer
Jane Morgan

Lung cancer remains the leading cause of cancer-related deaths in men and women, accounting for 1 in every 4 deaths caused by cancer in the United States. However, recent advances in immunotherapy, especially those called “immune checkpoint inhibitors,” bring new hope for patients with lung cancer.

Recommended For You
Lung Cancer
Biomarkers in Lung Cancer: What Are They and Why Do They Matter?
By Upal Basu Roy, PhD, MPH
Lung cancer continues to be the second most common cancer in the United States and the leading cause of cancer-related death for men and for women. Lung cancer is often diagnosed in a later stage, when treatment may be more challenging than when the cancer is detected early.
Lung Cancer
Treatment of Non–Small-Cell Lung Cancer: A Guide for Patients
By Blanca A. Ledezma, MSN, NP, Edward B. Garon, MD
In the second article of this 4-part series, the authors present an overview of the current treatment landscape for NSCLC, including a description of the most often used treatments and common questions that patients can ask their providers.
COVID-19 (Coronavirus)Lung CancerWeb Exclusives
Updated Joint Statement on Coronavirus (COVID-19) from Lung Cancer Groups
LUNGevity and 4 other lung cancer organizations have provided information on the new coronavirus for people with lung cancer and other patients with cancer. This update also provides reliable sources of information for patients.
COVID-19 (Coronavirus)Lung CancerWeb Exclusives
COVID-19 FAQs for People with Lung Cancer
LUNGevity answers some frequently asked questions about patients with lung cancer and survivors and the coronavirus illness.
Last modified: January 4, 2019

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.

Country